Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wnt signalling and prostate cancer.

G W Yardy1, S F Brewster

  • 1Cancer & Immunogenetics Laboratory, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK. george.yardy@cancer.org.uk

Prostate Cancer and Prostatic Diseases
|April 6, 2005
PubMed
Summary

The Wnt signaling pathway is crucial for development and stem cells. Alterations in this pathway, particularly involving beta-catenin, are linked to various cancers, including urological malignancies, offering prognostic insights and therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of aspirin with PC-SPES may not prevent pulmonary embolism.

BJU international·2009
Same author

Long-term outcomes and morbidity after I125 brachytherapy for localised prostate cancer: an early UK series.

Clinical oncology (Royal College of Radiologists (Great Britain))·2005
Same author

Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor.

BJU international·2003
Same author

Attitudes and use of alternative therapies in UK prostate cancer patients-isn't it time we were in the know?

Prostate cancer and prostatic diseases·2002
Same author

Growth factors and their receptors in prostate cancer.

BJU international·2002
Same author

An outbreak of Pseudomonas aeruginosa infection associated with contaminated urodynamic equipment.

The Journal of hospital infection·2001

Area of Science:

  • Developmental Biology
  • Cancer Biology
  • Molecular Signaling

Background:

  • The Wnt signaling pathway regulates embryological development and stem cell maintenance.
  • Heritable genetic and epigenetic alterations in Wnt pathway genes are observed in numerous cancers.
  • Disruption of the Wnt pathway is implicated as a key factor in tumorigenesis.

Purpose of the Study:

  • To explore the role of the Wnt signaling pathway in cancer development.
  • To investigate the significance of Wnt pathway components, such as beta-catenin, in urological malignancies.
  • To assess the potential of Wnt pathway alterations as prognostic markers and therapeutic targets.

Main Methods:

  • Review of existing literature on Wnt signaling in development and cancer.

Related Experiment Videos

  • Analysis of gene mutations and expression patterns within the Wnt pathway in tumor samples.
  • Examination of interactions between Wnt pathway molecules (e.g., beta-catenin) and other relevant receptors (e.g., androgen receptor).

    • Main Results:

    • Wnt pathway alterations are frequently found in various cancers.
    • Interactions between beta-catenin and the androgen receptor are relevant to urological cancers.
    • Wnt gene mutations or altered expression may provide prognostic information.

    Conclusions:

    • The Wnt signaling pathway is a significant player in cancer development and progression.
    • Targeting the Wnt pathway holds promise for novel cancer therapies.
    • Wnt pathway status in tumors can inform prognosis and guide treatment strategies.